An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability

被引:11
|
作者
De Groef, An [1 ,2 ]
Van Kampen, Marijke [1 ,2 ]
Vervloesem, Nele [1 ,2 ]
De Geyter, Sophie [1 ,2 ]
Dieltjens, Evi [1 ,2 ]
Christiaens, Marie-Rose [3 ,4 ]
Neven, Patrick [3 ,5 ]
Geraerts, Inge [1 ,2 ]
Devoogdt, Nele [1 ,2 ]
机构
[1] Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium
[3] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium
[4] Univ Leuven, KU Leuven, Dept Surg Oncol, Leuven, Belgium
[5] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
TRIGGER POINTS; PAIN; SURGERY;
D O I
10.1371/journal.pone.0179116
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. Methods 1) Development of the evaluation tool. Literature was searched, experts in the field of myofascial therapy were consulted and pilot testing was performed. 2) Thirty patients (63% had a mastectomy, 37% breast-conserving surgery and 97% radiotherapy) with myofascial adhesions were evaluated using the developed tool by 2 independent raters. The Weighted Kappa (WK) and the intra-class correlation coefficient (ICC) were calculated. Results 1) The evaluation tool for Myofascial Adhesions in Patients with Breast Cancer (MAP-BC evaluation tool) consisted of the assessment of myofascial adhesions at 7 locations: axillary and breast region scars, musculi pectorales region, axilla, frontal chest wall, lateral chest wall and the inframammary fold. At each location the degree of the myofascial adhesion was scored at three levels (skin, superficial and deep) on a 4-points scale (between no adhesions and very stiff adhesions). Additionally, a total score (0-9) was calculated, i.e. the sum of the different levels of each location. 2) Interrater agreement of the different levels separately was moderate for the axillary and mastectomy scar (WK 0.62-0.73) and good for the scar on the breast (WK > 0.75). Moderate agreement was reached for almost all levels of the non-scar locations. Interrater reliability of the total scores was the highest for the scars (ICC0.82-0.99). At non-scar locations good interrater reliability was reached, except for the inframammary fold (ICC = 0.71). Conclusions The total scores of all locations of the MAP-BC evaluation tool had good to excellent interrater reliability, except for the inframammary fold which only reached moderate reliability.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Development and evaluation of a computerized clinical outcome assessment tool for head and neck cancer patients
    Lin, Ching-Rong
    Fan, Kang-Hsing
    Lin, Chien-Yu
    Hung, Tsung-Min
    Huang, Bing-Shen
    Chen, Eric Yen-Chao
    Kang, Chung-Jan
    Huang, Shiang-Fu
    Chang, Joseph Tung-Chieh
    Chang, Chih-Hung
    MEDICINE, 2020, 99 (34)
  • [22] Development and evaluation of a cancer risk educational tool (CREdIT) for women with a family history of breast and ovarian cancer.
    Wilcox, C.
    Lee, R.
    Beattie, M.
    Luce, J.
    Joseph, G.
    Lamvik, K.
    Crawford, B.
    Ziegler, J.
    Braithwaite, D.
    CANCER RESEARCH, 2009, 69 (02) : 186S - 187S
  • [23] Development and evaluation of a triage tool for patients in a dental emergency' unit
    Pegon-Machat, Estelle
    Decerle, Nicolas
    Tubert-Jeannin, Stephanie
    SANTE PUBLIQUE, 2015, 27 (01): : 79 - 88
  • [24] The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer - a potential tool for breast cancer risk assessment and biomarker evaluation
    Visvanathan, K.
    Santor, D.
    Ali, S. Z.
    Brewster, A.
    Arnold, A.
    Armstrong, D. K.
    Davidson, N. E.
    Helzlsouer, K. J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (05) : 950 - 955
  • [25] Evaluation of spirometry test as monitoring tool in lung cancer patients
    Aggarwal, Deepak
    Saini, Varinder
    Janmeja, Ashok
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [26] Intra- and Interrater Reliability and Concurrent Validity of a New Tool for Assessment of Breast Cancer-Related Lymphedema of the Upper Extremity
    Spinelli, Bryan
    Kallan, Michael J.
    Zhang, Xiaochen
    Cheville, Andrea
    Troxel, Andrea
    Cohn, Joy
    Dean, Lorraine
    Sturgeon, Kathleen
    Evangelista, Margaret
    Zhang, Zi
    Ebaugh, David
    Schmitz, Kathryn H.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2019, 100 (02): : 315 - 326
  • [27] Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy
    Fowler, Eileen G.
    Staudt, Loretta A.
    Greenberg, Marcia B.
    Oppenheim, William L.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2009, 51 (08): : 607 - 614
  • [28] Development, internal reliability and preliminary construct validity of the Dutch Dietary Intention Evaluation Tool for In-patients (DIETI)
    de Frel, Daan L.
    Wicks, Hope
    Bakk, Zsuzsa
    van Keulen, Nicole
    van Adrichem, Vrouwke
    van Tussenbroek, Nikki
    Atsma, Prof Douwe E.
    Janssen, Veronica R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (01) : 56 - 64
  • [29] Development of a tool for comprehensive evaluation of population-based cancer registries
    Sheikhtaheri, Abbas
    Nahvijou, Azin
    Sedighi, Zahra
    Hadji, Maryam
    Golmahi, Mohammad
    Roshandel, Gholamreza
    Beiki, Omid
    Ravankhah, Zahra
    Zendehdel, Kazem
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2018, 117 : 26 - 32
  • [30] Evaluation of Tumour Markers as Differential Diagnostic Tool in Patients with Suspicion of Liver Metastases from Breast Cancer
    Liska, Vaclav
    Holubec, Lubos, Jr.
    Treska, Vladislav
    Vrzalova, Jindra
    Skalicky, Tomas
    Sutnar, Alan
    Kormunda, Stanislav
    Bruha, Jan
    Vycital, Ondrej
    Finek, Jindrich
    Pesta, Martin
    Pecen, Ladislav
    Topolcan, Ondrej
    ANTICANCER RESEARCH, 2011, 31 (04) : 1447 - 1451